Core Viewpoint - Zhongji Health Industry Co., Ltd. and its wholly-owned subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., are undergoing pre-restructuring due to inability to repay debts and lack of repayment capacity, but both entities are deemed to have restructuring value [1][2]. Group 1: Company Restructuring - Zhongji Health received a pre-restructuring notice from the Sixth Division Intermediate People's Court of Xinjiang Production and Construction Corps on July 28, 2025 [2][14]. - The court has appointed temporary administrators for both Zhongji Health and its subsidiary, Red Tomato, to oversee the pre-restructuring process [14]. - Creditors are required to submit their claims by August 28, 2025, detailing their basic information, the formation of the debt, and the amount owed [15]. Group 2: Financial Status and Compliance - As of the report date, the company has no major illegal activities that could lead to the termination of its stock listing related to national security, public safety, ecological safety, production safety, or public health [2][3][4]. - There are no significant violations regarding fraudulent issuance, major information disclosure violations, or other serious damages to the securities market order that could lead to stock termination [3][4]. - The company has confirmed that there are no non-operational fund occupations by controlling shareholders or related parties [5][7]. Group 3: Stock Listing and Risk Warnings - The company’s stock has been under "delisting risk warning" since April 1, 2025, due to negative financial results, including a negative total profit and net profit for the fiscal year 2024 [9][10]. - If the court accepts the restructuring application, the stock will face additional delisting risk warnings [10][19]. - The company will continue to monitor the restructuring process and will disclose updates as necessary [10].

证券代码：000972 证券简称：*ST 中基 公告编号：2025-062 号 中基健康产业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）分别收到新疆生产建设兵团第 六师中级人民法院（以下简称"六师中院"或"法院"）送达的《预重整通知书》[（2025） 兵 06 破申（预）1 号、（2025）兵 06 破申（预）2 号]。六师中院通知启动对公司及红色番茄 的预重整，并指定公司清算组担任公司临时管理人、红色番茄清算组担任红色番茄临时管理人 （以下合称"临时管理人"）。 联系电话：18109910119、18109910120 联系邮箱：zjjkglr@163.com 联系时间：工作日上午 10:30-13:30，下午 4:00－7:30 联系地址：新疆维吾尔自治区乌鲁木齐市天山区青年路北一巷 8 号中基大厦 4 层 详细内容请以全国企业破产重整案件信息网（https://pccz.court.gov.cn/）上发布的公告为 现临时管理人就公司及子公司红色番茄预重整期间债权申报的相关内容公告如下 ...

Group 1 - The core point of the article highlights the financial performance and stock market activity of *ST Zhongji, indicating a decline in revenue and profit for the first quarter of 2025 [1] - As of July 29, 2025, *ST Zhongji's stock closed at 3.29 yuan, down 0.6%, with a turnover rate of 5.62% and a trading volume of 433,400 hands, amounting to 146 million yuan [1] - The company experienced a net outflow of 21.7 million yuan in main funds, accounting for 14.87% of the transaction amount, with significant outflows from large orders [1] Group 2 - For the first quarter of 2025, *ST Zhongji reported total operating revenue of 78.69 million yuan, a year-on-year decrease of 34.01%, and a net profit attributable to shareholders of 7.26 million yuan, down 221.28% [1] - The company's current ratio is 0.790, quick ratio is 0.148, and debt-to-asset ratio is 101.54%, indicating potential liquidity issues [1] - Established in 1994, Zhongji Health Industry Co., Ltd. focuses on capital market services and has a registered capital of 771.28 million yuan [1][2]

证券代码：000972 证券简称：*ST 中基 公告编号：2025-061 号 中基健康产业股份有限公司 关于公司及下属全资子公司被债权人申请重整及预重整的专项自查报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 中基健康产业股份有限公司（以下简称"公司"）于近日获悉，中兴财光华会计师事务所 （特殊普通合伙）（以下简称"中兴财光华"）以公司不能清偿到期债务且明显缺乏清偿能力， 但具有重整价值为由，于 2025 年 7 月 25 日向新疆生产建设兵团第六师中级人民法院（以下简 称"六师中院"或"法院"）申请对公司进行重整及预重整，并提交了相关材料。 截至本报告披露日，公司不存在因涉及国家安全、公共安全、生态安全、生产安全和公众 健康安全等领域的重大违法行为而导致股票可能被终止上市的情形。 公司下属全资子公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）于近日获 悉，新疆恒源水务有限公司（以下简称"恒源水务"）以红色番茄不能清偿到期债务且明显缺 乏清偿能力，但具有重整价值为由，于 2025 年 7 月 25 日向六师中院申请对红色番茄进行重整 及预重整，并 ...

证券代码：000972 证券简称：*ST 中基 公告编号：2025-062 号 中基健康产业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 2025 年 7 月 28 日，中基健康产业股份有限公司（以下简称"公司"）及公司下属全资子 公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）分别收到新疆生产建设兵团第 六师中级人民法院（以下简称"六师中院"或"法院"）送达的《预重整通知书》[（2025） 兵 06 破申（预）1 号、（2025）兵 06 破申（预）2 号]。六师中院通知启动对公司及红色番茄 的预重整，并指定公司清算组担任公司临时管理人、红色番茄清算组担任红色番茄临时管理人 （以下合称"临时管理人"）。 现临时管理人就公司及子公司红色番茄预重整期间债权申报的相关内容公告如下： 一、债权申报期间及内容 公司及子公司红色番茄的债权人应于 2025 年 8 月 28 日（含当日）前向临时管理人申报债 权，书面说明债权人基本信息、债权的形成过程、债权金额（包括本金数额、截至预重整之日 的孳息数额、孳息计算方法和利息清单等）、有无财产担保、是否为 ...

Core Viewpoint - Zhongji Health Industry Co., Ltd. and its wholly-owned subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., have been applied for reorganization and pre-reorganization by creditors due to their inability to repay debts and lack of repayment capacity, but they possess reorganization value [1][2][3] Group 1: Company Overview - Zhongji Health Industry Co., Ltd. has been facing financial difficulties, with total assets of approximately 1.62 billion yuan and total liabilities of about 1.64 billion yuan as of March 31, 2025 [6] - The company reported a net profit of -725.57 million yuan for the first quarter of 2025, and its annual net profit for 2024 was -2.31 billion yuan [6][13] - The subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., also reported significant losses, with a net profit of -713.03 million yuan for the first quarter of 2025 [7] Group 2: Legal Proceedings - On July 25, 2025, Zhongji Health and its subsidiary were applied for pre-reorganization by creditors, with the court officially notifying the initiation of pre-reorganization on July 28, 2025 [2][8] - The court has appointed a temporary management team to oversee the reorganization process, which includes investigating the debtor's financial situation and supervising asset management [9][10] Group 3: Financial Impact - The company has been under "delisting risk warning" since April 1, 2025, due to negative net assets and insufficient revenue [13][14] - The ongoing pre-reorganization does not guarantee that the court will accept the reorganization applications, and the future of the company remains uncertain [11][12]

证券代码：000972 证券简称：*ST 中基 公告编号：2025-060 号 中基健康产业股份有限公司 关于公司及下属全资子公司被债权人申请重整与预重整 暨法院启动预重整并指定临时管理人的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 特别提示： 1、中基健康产业股份有限公司（以下简称"公司"）于近日获悉，中兴财光华会计师事务 所（特殊普通合伙）（以下简称"中兴财光华"）以公司不能清偿到期债务且明显缺乏清偿 能力，但具有重整价值为由，于 2025 年 7 月 25 日向新疆生产建设兵团第六师中级人民法院 （以下简称"六师中院"或"法院"）申请对公司进行重整及预重整，并提交了相关材料。 公司下属全资子公司新疆中基红色番茄产业有限公司（以下简称"红色番茄"）于近日获悉， 新疆恒源水务有限公司（以下简称"恒源水务"）以红色番茄不能清偿到期债务且明显缺乏 清偿能力，但具有重整价值为由，于 2025 年 7 月 25 日向六师中院申请对红色番茄进行重整及 预重整，并提交了相关材料。 2、2025 年 7 月 28 日，公司收到六师中院送达的《预重整通知书》[（20 ...

Group 1: M&A Activity Overview - From July 14 to July 20, there were 77 M&A events involving listed companies, with 27 classified as significant M&A transactions[9] - Out of the total M&A events, 12 were completed, including 1 significant M&A transaction involving Baota Industrial[9] - There were 3 failed M&A attempts by listed companies, specifically by Lixing Co., Hongming Co., and Zhongji Health[15] Group 2: Policy Updates - On July 18, Tianjin's financial authorities released measures to support M&A, focusing on 12 key industrial chains and establishing a resource pool for quality M&A targets[7] - The Shanghai G60 Science and Technology Innovation Group held a summit on July 16 to discuss M&A and overseas expansion in the context of innovation and industry leadership[7] Group 3: Market Performance - During the week of July 14 to July 20, the restructuring index outperformed the Wind All A index by 0.27%[19] - Over a mid-term view, the restructuring index's rolling 20-day return shifted from negative to positive compared to the Wind All A index[19] Group 4: Control Changes - Two listed companies reported changes in actual control during this period, with Shenjian Co. and Hualan Group undergoing ownership transitions[17]

中基健康产业股份有限公司 关于下属全资子公司获得政府补助的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 证券代码：000972 证券简称：*ST 中基 公告编号：2025-059 号 一、基本情况 中基健康产业股份有限公司（以下简称"公司"）下属全资子公司新疆中基红色番茄产业有 限公司（以下简称"红色番茄"）于 2025 年 7 月 22 日收到现金形式的政府补助 6,028.74 万元。 上述政府补助与红色番茄日常经营活动相关，属于与收益相关的政府补助，以上金额占 2024 年经审计归属于上市公司股东的净利润绝对值的 26.12%。该政府补助预计 6,028.74 万元计入 2025 年度损益，将对红色番茄及公司 2025 年度利润产生正面影响，本补助不具有可持续性。 二、补助类型及对上市公司的影响 根据《企业会计准则第 16 号—政府补助》的规定，本次收到的政府补助为与收益相关的 政府补助，用于补偿已发生的相关成本费用或损失，计入其他收益。 特此公告。 中基健康产业股份有限公司董事会 2025 年 7 月 22 日 红色番茄为公司全资子公司，上述政府 ...

Performance Forecast - The company expects a net loss attributable to shareholders of between 60 million to 90 million yuan, compared to a profit of 11.8014 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is expected to be a loss of 65 million to 95 million yuan, compared to a profit of 3.1979 million yuan last year [1] - The basic earnings per share is projected to be a loss of 0.0778 yuan to 0.1167 yuan, compared to a profit of 0.0153 yuan per share last year [1] Communication with Auditors - The performance forecast has not been reviewed by the accounting firm, but preliminary discussions have taken place, and there are no significant disagreements regarding the forecast [1] Reasons for Performance Changes - Despite a 160% year-on-year increase in sales volume of bulk tomato sauce, the average selling price decreased by approximately 60%, leading to a gross profit decline of about 170% [1] - The total amount of existing borrowings has increased, resulting in a 60% year-on-year increase in interest expenses [1]